Somerset-based Catalent Inc., a provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, is acquiring Cook Pharmica LLC for $950 ...

BLOOMINGTON, Ind. – June 18, 2012 – In a decision that paves the way for greater pharmaceutical industry use of the company's contract manufacturing services, Cook Pharmica LLC has received its first ...

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Veda Walcott has been named vice president of quality and corporate compliance officer of Cook Pharmica, the global biopharmaceutical contract development and ...

Cook Pharmica, LLC, a privately-held contract development and manufacturing organization serving the biopharmaceutical industry, plans to expand its operations in Bloomington, IN, creating up to 70 ...

The acquisition adds to Catalent’s capabilities in biologics development, analytical services, manufacturing, and finished product supply. Catalent has made the latest move in the restructuring of the ...

Catalent signaled a year ago that it was looking for the right M&A target to bulk up like some of its competitors have. Now it says it has found one, having agreed to pay $950 million to buy Cook ...

BLOOMINGTON, Ind. (WTHR) - As one of the largest employers in Monroe County Cook Medical is about to get bigger and smaller at the same time. It is selling Cook Pharmica to Catalent for $950 million.

Biopharmaceutical companies have to take many variables into consideration when bringing a product to market. If they are working with several CMOs, they will likely encounter problematic ...

Cook Pharmica LLC plans to spend $28 million and hire 70 workers to add a new drug-filling line at its Bloomington facility, company and state officials announced Monday morning. Cook Pharmica, a ...

Catalent said today it agreed to acquire Cook Pharmica for $950 million in a deal that would continue the consolidation of contract development and manufacturing organizations (CDMOs), to which ...

Approval has Already Spurred Growing Interest from Major Biopharmaceutical Companies BLOOMINGTON, Ind.-- In a decision that paves the way for greater pharmaceutical industry use of the company's ...